EFFALA 8 mg, medicated plaster sachet
Active ingredients: Aminolevulinic acid hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Medicated plastersachetcutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EFFALA 8 mg, emplâtre médicamenteux
- Pharmaceutical form
- emplâtre médicamenteux(se)
- Route of administration
- cutanée
- Presentation description
- 1 sachet(s) papier polyéthylène basse densité (PEBD) aluminium copolymère d'éthylène de 4 emplâtre(s)
- Marketing authorisation holder
- PHOTONAMIC (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Jun 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69357111CIP73979964CIP133400939799643Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE L'ACIDE 5-AMINOLÉVULINIQUEemplâtre | 8 mg · un emplâtre | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.